Albendazole 400 mg

DRUG2 trials

Sponsors

GlaxoSmithKline, Jennifer Keiser

Conditions

Intestinal DiseasesTrichuris Infection

Phase 1

Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions

CompletedNCT06201559

GlaxoSmithKlineIntestinal Diseases

Start: 2023-08-21End: 2023-09-12Updated: 2025-01-27

Phase 2

Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita

Not yet recruitingNCT07258173

Jennifer KeiserTrichuris Infection

Start: 2026-05-15End: 2026-09-15Target: 100Updated: 2026-05-08